Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506

Cancer Research

Volumn 61, Issue 18, 2001, Pages 6876-6884

  Pilch, Bartosz ^a   Allemand, Eric ^a   Facompré, Michael ^c   Bailly, Christian ^c   Riou, Jean Franêois ^b   Soret, Johann ^a   Tazi, Jamal ^a  

^a UNIV MONTPELLIER   (France)

^b UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

6 FORMYLAMINO 12,13 DIHYDRO 1,11 DIHYDROXY 5H INDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE 5,7(6H) DIONE 13 GLUCOSIDE; DNA TOPOISOMERASE;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; SPLICEOSOME;

ANIMALS; CARBAZOLES; DNA TOPOISOMERASES, TYPE I; GLUCOSIDES; HELA CELLS; HUMANS; LEUKEMIA P388; MICE; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PHOSPHORYLATION; RNA PRECURSORS; RNA SPLICING; RNA, MESSENGER; RNA-BINDING PROTEINS; SPLICEOSOMES; TUMOR CELLS, CULTURED;

EID: 0035884180     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Regulation of pre-mRNA splicing in metazoa
2. Alternative splicing and programmed cell death
3. The regulation of splice-site selection, and its role in human disease
4. Mechanical devices of the spliceosome: Motors, clocks, springs, and things
5. The superfamily of arginine/serine-rich splicing factors
6. SR proteins: A conserved family of pre-mRNA splicing factors
7. Initial splice site recognition and pairing during pre-mRNA splicing
8. Specific interactions between proteins implicated in splice site selection and regulated alternative splicing
9. Phosphorylation regulates in vivo interaction and molecular targeting of serine/arginine-rich pre mRNA splicing factors
10. Phosphorylation of the ASF/SF2 RS domain affects both protein-protein and protein-RNA interactions and is necessary for splicing
11. Phosphorylation-dephosphorylation differentially affects activities of splicing factor ASF/SF2
12. Thiophosphorylation of U1-70K protein inhibits pre-mRNA splicing
13. The protein kinase Clk/Sty directly modulates SR protein activity: Both hyper- and hypophosphorylation inhibit splicing
14. Both phosphorylation and dephosphorylation of ASF/SF2 are required for pre-mRNA splicing in vitro
15. DNA topoisomerase I: Customs officer at the border between DNA and RNA worlds?
16. Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme
17. DNA topoisomerases
18. Specific phosphorylation of SR proteins by mammalian DNA topoisomerase I
19. The C-terminal domain but not the tyrosine 723 of human DNA topoisomerase I active site contributes to kinase activity
20. Interaction between the N-terminal domain of human DNA topoisomerase I and the arginine-serine domain of its substrate determines phosphorylation of SF2/ASF splicing factor
21. Novel indolocarbazole compound 6-N-formylamino 12, 13-dihydro-1, 11-dihydroxy-13-(β-D-glucopyranosyl)-5H-indolo[2.3-a]pyrrolo- [3, 4-c]carbazole-5, 7(6H)-dione (NB-506): Its potent antitumor activities in mice
22. Intercalation into DNA is not required for inhibition of topoisomerase I by indolocarbazole antitumor agents
23. Syntheses, biochemical and biological evaluation of staurosporine analogues from the microbial metabolite rebeccamycin
24. Synthesis and biological activities of NB-506 analogues: Effects of the positions of two hydroxyl groups at the indole rings
25. Sequential modifications of topoisomerase I activity in a camptothecin-resistant cell line established by progressive adaptation
26. Sensitive and high-resolution detection of RNA in situ
27. A protein that specifically recognizes the 3′ splice site of mammalian pre-mRNA introns is associated with a small nuclear ribonucleoprotein
28. Recognition of exonic splicing enhancer sequences by the Drosophila splicing repressor RSFI
29. Interactions between small nuclear ribonucleoprotein particles in formation of spliceosomes
30. Use of camptothecin-resistant mammalian cell lines to evaluate the role of topoisomerase I in the antiproliferative activity of the indolocarbazole, NB-506, and its topoisomerase I binding site
31. Poisoning of topoisomerase I by an antitumor indolocarbazole drug: Stabilization of topoisomerase I-DNA covalent complexes and specific inhibition of the protein kinase activity
32. Yeast as a model organism for studying the actions of DNA topoisomerase-targeted drugs
33. Inefficient processing impairs release of RNA from the site of transcription
34. Poly(A) RNA codistribution with microfilaments: Evaluation by in xitu hybridization and quantitative digital imaging microscopy
35. B. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death
36. The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor. Comparison of all 10 variable exons between mouse, human, and rat
37. SC35 autoregulates its expression by promoting splicing events that destabilize its mRNAs
38. Alternative splicing of STY, a nuclear dual specificity kinase
39. Serine phosphorylation of SR proteins is required for their recruitment to sites of transcription in vivo